• Keine Ergebnisse gefunden

Acharya P, Beckel J, Ruiz WG, Wang E, Rojas R, Birder L, Apodaca G.

Distribution of the tight junction proteins ZO1, occludin, and claudin4, 8, and -12 in bladder epithelium. Am J Physiol Renal Physiol. 2004 Aug;287(2):F305-18.

Adler S, Pellizzer C, Paparella M, Hartung T, Bremer S. The effects of solvents on embryonic stem cell differentiation. Toxicol In Vitro. 2006 Apr;20(3):265-71.

Epub 2005 Aug 19.

Aijaz S, Balda MS, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol. 2006;248:261-98. Review.

Alexandre MD, Lu Q, Chen YH. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells.J Cell Sci. 2005 Jun 15;118(Pt 12):2683-93.

Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene.

2002 Apr 18;21(17):2634-40.

Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells.J Cell Sci. 2002 Dec 15;115(Pt 24):4969-76.

Amemori S, Iwakiri R, Endo H, Ootani A, Ogata S, Noda T, Tsunada S, Sakata H, Matsunaga H, Mizuguchi M, Ikeda Y, Fujimoto K. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J Gastroenterol. 2006 May;41(5):444-9.

Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005 Aug 15;65(16):7378-85.

Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics Nat Rev Cancer. 2002 Dec;2(12):897-909. Review.

Blackman B, Russell T, Nordeen SK, Medina D, Neville MC. Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors. Breast Cancer Res. 2005;7(2):R248-55.

Bolduc L, Labrecque B, Cordeau M, Blanchette M, Chabot B. Dimethyl sulfoxide affects the selection of splice sites. J Biol Chem. 2001 May 18;276(20):17597-602. Epub 2001 Mar 1.

Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.J Cell Sci. 2003 Feb 1;116(Pt 3):499-511.

Breitman TR, Gallo RC. New facts and speculations on human myeloid leukemias. Blood Cells. 1981;7(1):79-89.

Chen Y, Lu Q, Schneeberger EE, Goodenough DA. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells.

Mol Biol Cell. 2000 Mar;11(3):849-62.

Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, Osanai M, Kojima T, Sawada N. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Exp Cell Res. 2005 Jan 1;302(1):11-21.

Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15191-6.

Coyne CB, Gambling TM, Boucher RC, Carson JL, Johnson LG. Role of claudin interactions in airway tight junctional permeability.Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1166-78. Epub 2003 Aug 8

Dansranjavin T, Möbius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H.. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases. Oncol Rep. 2006 May;15(5):1125-31.

Daugherty BL, Mateescu M, Patel AS, Wade K, Kimura S, Gonzales LW, Guttentag S, Ballard PL, Koval M. Developmental regulation of claudin localization by fetal alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol.

2004 Dec;287(6):L1266-73.

Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005 Jul;115(7):1765-76.

Elsasser HP, Lehr U, Agricola B, Kern HF. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61(5):295-306

Evers BM, Rady PL, Tyring SK, Sanchez RL, Rajaraman S, Townsend CM Jr, Thompson JC. Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery. 1992 Aug;112(2):211-7; discussion 217-8.

Friess H, Guo XZ, Nan BC, Kleeff O, Buchler MW. Growth factors and cytokines in pancreatic carcinogenesis. Ann N Y Acad Sci. 1999 Jun 30;880:110-21.

Review.

Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S.

Occludin: a novel integral membrane protein localizing at tight junctions.J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88.

Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998 Jun 29;141(7):1539-50.

Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 1999 Nov 15;147(4):891-903.

Gao L, Macara IG. Isoforms of the polarity protein par6 have distinct functions. J Biol Chem. 2004 Oct 1;279(40):41557-62. Epub 2004 Jul 28.

Giehl K, Skripczynski B, Mansard A, Menke A, Gierschik P. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene. 2000 Jun 8;19(25):2930-42.

Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins.Prog Biophys Mol Biol. 2003 Jan;81(1):1-44. Review. PMID: 12475568 Gonzalez-Mariscal L, Namorado Mdel C, Martin D, Sierra G, Reyes JL. The tight junction proteins claudin-7 and -8 display a different subcellular localization at Henle's loops and collecting ducts of rabbit kidney. Nephrol Dial Transplant.

2006 Sep;21(9):2391-8.

Guan X, Inai T, Shibata Y. Segment-specific expression of tight junction proteins, claudin-2 and -10, in the rat epididymal epithelium.Arch Histol Cytol.

2005 Sep;68(3):213-25.

Guenther R, Krenn V, Morawietz L, Dankof A, Melcher I, Schaser KD, Kasper HU, Kuban RJ, Ungethum U, Sers C. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR. Pathol Res Pract. 2005;201(10):649-63.

Harrington KJ, Syrigos KN. The role of E-cadherin-catenin complex: more than an intercellular glue? Ann Surg Oncol. 2000 Dec;7(10):783-8. Review.

Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.Cancer Res.

2001 Mar 1;61(5):2320-7

He Y, Yang B, Ruan CG. [Anti-pancreatic cancer immune response induced by K-ras mutated peptide] Ai Zheng. 2005 May;24(5):559-62.

Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006 Jul 12;6:186.

Hoormann S. Klonierung und Charakterisierung von Claudin-2, einem in Pankreaskarzinomzellen metastastierungs-assoziiert exprimierten integralen Tight Junction-Membrabprotein, Marburg 2007

Inai T, Sengoku A, Guan X, Hirose E, Iida H, Shibata Y. Heterogeneity in expression and subcellular localization of tight junction proteins, claudin-10 and -15, examined by RT-PCR and immunofluorescence microscopy. Arch Histol Cytol. 2005 Dec;68(5):349-60.

Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins.J Cell Biol. 1999 Dec 13;147(6):1351-63.

Iwamura T, Katsuki T, Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9.Jpn J Cancer Res. 1987 Jan;78(1):54-62.

Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S, Shiota K.

Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body.

Stem Cells. 2006 Nov;24(11):2549-56. Epub 2006 Jul 13.

Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, Moskaluk CA, El-Rifai W. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol. 2005 Aug;167(2):577-84.

Kainuma O, Asano T, Hasegawa M, Kenmochi T, Nakagohri T, Tokoro Y, Isono K. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin.Pancreas. 1997 Nov;15(4):379-83.

Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.Mol Pharmacol. 2004 Jan;65(1):18-27.

Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer. 2003 Jan 22;2:14. Review.

Kim YW, Kern HF, Mullins TD, Koriwchak MJ, Metzgar RS. Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas. 1989;4(3):353-62.

Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology. 2000 Jun;118(6):1001-11.

Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Cancer Res. 1968 Jul;28(7):1300-10.

Koenig A, Mueller C, Hasel C, Adler G, Menke A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006 May 1;66(9):4662-71.

Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.Oncogene. 2003 Apr 3;22(13):2021-33.

Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S.

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4 Am J Pathol. 2004 May;164(5):1627-33.

Kuwabara H, Kokai Y, Kojima T, Takakuwa R, Mori M, Sawada N. Occludin regulates actin cytoskeleton in endothelial cells.Cell Struct Funct. 2001 Apr;26(2):109-16.

Kyriazis AP, DiPersio L, Michael GJ, Pesce AJ, Stinnett JD. Growth patterns and metastatic behavior of human tumors growing in athymic mice.Cancer Res.

1978 Oct;38(10):3186-90

Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zoller M. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res. 2005 Oct 1;309(2):345-57.

Lamas M, Gonzalez-Mariscal L, Gutierrez R. Presence of claudins mRNA in the brain. Selective modulation of expression by kindling epilepsy.Brain Res Mol Brain Res. 2002 Aug 15;104(2):250-4.

Lan M, Kojima T, Osanai M, Chiba H, Sawada N. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line.Carcinogenesis. 2004 Dec;25(12):2385-95.

Li D, Mrsny RJ. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin J Cell Biol. 2000 Feb 21;148(4):791-800.

Li WY, Huey CL, Yu AS Expression of claudin-7 and -8 along the mouse nephron. Am J Physiol Renal Physiol. 2004 Jun;286(6):F1063-71.

Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976 Jan 15;17(1):62-70.

Lipschutz JH, Li S, Arisco A, Balkovetz DF. Extracellular-signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem. 2004 Nov 29; 280(5):3780-8.

Lodi C, Szabo E, Holczbauer A, Batmunkh E, Szijarto A, Kupcsulik P, Kovalszky I, Paku S, Illyes G, Kiss A, Schaff Z. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol. 2006 Mar;19(3):460-9.

Lo Monaco GB. [Line of HeLa cells proliferating in medium containing calf serum.] Sperimentale. 1957 Jan-Feb;107(1):56-62. Italian.

Long H, Crean CD, Lee WH, Cummings OW, Gabig TG. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 2001 Nov 1;61(21):7878-81.

Lozzio BB, Lozzi CB, Machado E. Human myelogenous (Ph+) leukemia cell line: transplantation into athymic mice. J Natl Cancer Inst. 1976 Mar;56(3):627-9.

Macara IG. Par proteins: partners in polarization. Curr Biol. 2004 Feb 17;14(4):R160-2. Review. McNeil et al., 2006.

MageshV, Singh JP, Selvendiran K. Ekambaram G, Sakthisekaran D. Antitumor activity of cocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem. 2006 Jul;127-35.

McNeil E, Capaldo CT, Macara IG. Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells.Mol Biol Cell.

2006 Apr;17(4):1922-32. Epub 2006 Jan 25.

Medici D, Hay ED, Goodenough DA. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell. 2006 Apr;17(4):1871-9. Epub 2006 Feb 8.

Metzgar RS, Gaillard MT, Levine SJ, Tuck FL, Bossen EH, Borowitz MJ.

Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982 Feb;42(2):601-8.

Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology. 2001 Sep;121(3):678-84.

Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G, Gress TM. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.Cancer Res. 2003 Oct 1;63(19):6265-71.

Minowada, J., T. Ohnuma, and G. E. Moore. 1972. Rosette forming human lymphoid cell line. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49:891.

Mitic LL, Van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function:

lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol. 2000 Aug;279(2):G250-4. Review.

Montgomery E, Mamelak AJ, Gibson M, Maitra A, Sheikh S, Amr SS, Yang S, Brock M, Forastiere A, Zhang S, Murphy KM, Berg KD. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):24-30.

Morita K, Itoh M, Saitou M, Ando-Akatsuka Y, Furuse M, Yoneda K, Imamura S, Fujimoto K, Tsukita S. Subcellular distribution of tight junction-associated proteins (occludin, ZO-1, ZO-2) in rodent skin. J Invest Dermatol. 1998 Jun;110(6):862-6.

Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):511-6.

Morita K, Tsukita S, Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-ZO-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol. 2004 Aug;151(2):328-34.

Murata M, Kojima T, Yamamoto T, Go M, Takano K, Osanai M, Chiba H, Sawada N. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro.Exp Cell Res. 2005 Oct 15;310(1):140-51.

Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.Cancer Res. 1999 Nov 1;59(21):5464-70.

Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997 Feb 21;88(4):471-81.

Niimi T, Nagashima K, Ward JM, Minoo P, Zimonjic DB, Popescu NC, Kimura S. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol Cell Biol. 2001 Nov;21(21):7380-90.

Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S.

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003 May 12;161(3):653-60.

Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647-59.

Epub 2003 Dec 19.

Nunes FD, Lopez LN, Lin HW, Davies C, Azevedo RB, Gow A, Kachar B.

Distinct subdomain organization and molecular composition of a tight junction with adherens junction features. J Cell Sci. 2006 Dec 1;119(Pt 23):4819-27.

Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, Miyazaki N, Abe Y, Imaizumi T, Makuuchi H, Ueyama Y, Nakamura M. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol Rep. 2006 Sep;16(3):457-63.

O'Neill E, Kolch W. Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br J Cancer. 2004 Jan 26;90(2):283-8. Review.

Pulvertaft, R. J. V. A study of malignant tumors in Nigeria by short-term tissue culture. J. Clin. Pathol. 1965, 18:261-273.

Qian J, Niu J, Li M, Chiao PJ, Tsao MS. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.Cancer Res. 2005 Jun 15;65(12):5045-53.

Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.Gastroenterology. 2001 Feb;120(2):411-22.

Rajasekaran AK, Rajasekaran SA. Role of Na-K-ATPase in the assembly of tight junctions. Am J Physiol Renal Physiol. 2003 Sep;285(3):F388-96.

Rangel LB, Sherman-Baust CA, Wernyj RP, Schwartz DR, Cho KR, Morin PJ.

Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 2003 Oct 16;22(46):7225-32.

Reyes JL, Lamas M, Martin D, del Carmen Namorado M, Islas S, Luna J, Tauc M, Gonzalez-Mariscal L. The renal segmental distribution of claudins changes with development. Kidney Int. 2002 Aug;62(2):476-87.

Rinehart J, Adjei AA, Lorusso PM, Waterhouse D, Hecht JR, Natale RB, Hamid O, Varterasian M, Asbury P, Kaldjian EP, Gulyas S, Mitchell DY, Herrera R, Sebolt-Leopold JS, Meyer MB. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.J Clin Oncol. 2004 Nov 15;22(22):4456-62.

Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997 May 1;57(9):1731-4.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Cancer. 1997 Feb 15;79(4):700-16.

Saif MW, Karapanagiotou L, Syrigos K. Genetic alterations in pancreatic cancer. World J Gastroenterol. 2007 Sep 7;13(33):4423-30.

Sainz B Jr, Chisari FV. Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol. 2006 Oct;80(20):10253-7.

Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Inazawa J, Fujimoto K, Tsukita S. Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur J Cell Biol. 1997 Jul;73(3):222-31

Safran H, Steinhoff M, Mangray S, Rathore R, King TC, Chai L, Berzein K, Moore T, Iannitti D, Reiss P, Pasquariello T, Akerman P, Quirk D, Mass R, Goldstein L, Tantravahi U. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol. 2001 Oct;24(5):496-9.

Santin AD, Zhan F, Cane S. Gene expression fingerprint of unterine serous papillary carcinoma: identification of novel molecular markers of unterine serous cancer diagnosis and therapy. Br J Cancer 2005;92:1561-73

Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol. 2003 Apr 1;65(7):1035-41. Review.

Sauer T, Pedersen MK, Ebeltoft K, Naess O. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology. 2005 Aug;16(4):193-8.

Schramek H. MAP kinases: from intracellular signals to physiology and disease.News Physiol Sci. 2002 Apr;17:62-7. Review.

Shimizu K, Hanaoka M, Kato A, Fujii H, Honoki K, Tsujiuchi T. Reduced expression of the E-cadherin gene and its aberrant DNA methylation in hamster pancreatic tumors. Biochem Biophys Res Commun. 2005 Oct 14;336(1):49-53.

Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science. 1999 Jul 2;285(5424):103-6.

Singh AB, Harris RC. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem. 2004 Jan 30;279(5):3543-52.

Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours.

Histopathology. 2005 May;46(5):551-60.

Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 2003 Jul;200(4):448-64. Review.

Stevenson BR, Keon BH. The tight junction: morphology to molecules.Annu Rev Cell Dev Biol. 1998;14:89-109. Review.

Takai E, Tan X, Tamori Y, Hirota M, Egami H, Ogawa M. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells. Int J Oncol. 2005 Sep;27(3):645-51.

Tan X, Tamori Y, Egami H, Ishikawa S, Kurizaki T, Takai E, Hirota M, Ogawa M. Analysis of invasion-metastasis mechanism in pancreatic cancer:

involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.Oncol Rep. 2004 May;11(5):993-8.

Tan X, Egami H, Ishikawa S, Kurizaki T, Hirota M, Ogawa M. Zonula occludens-1 (ZO-occludens-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells. Dig Dis Sci. 2005 Aug;50(8):1402-9.

Thiery JP. Epithelial-mesenchymal transitions in tumour progression.Nat Rev Cancer. 2002 Jun;2(6):442-54. Review.

Troy TC, Rahbar R, Arabzadeh A, Cheung RM, Turksen K. Delayed epidermal permeability barrier formation and hair follicle aberrations in Inv-Cldn6 mice.

Mech Dev. 2005 Jun;122(6):805-19.

Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93. Review

Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, Matsui T, Tsukita S, Furuse M, Tsukita S. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation.

Cell. 2006 Aug 25;126(4):741-54.

Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Komori T, Ito A, Yokozaki H. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol. 2006 May;37(5):569-77.

Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 2001 May;107(10):1319-27

Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ.

Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell. 2002 Sep 20;110(6):789-99.

Wheadon H, Welham MJ. The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases. Blood. 2003 Aug 15;102(4):1480-9. Epub 2003 Apr 24.

Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH, Slebos RJ. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer. 1998 Jan 1;82(1):96-103.

Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, Sohn TA, Yeo CJ, Kern SE, Hruban RH. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol.

2000 Jan;156(1):37-43.

Wu X, Chen H, Parker B, Rubin E, Zhu T, Lee JS, Argani P, Sukumar S.

HOXB7, a Homeodomain Protein, Is Overexpressed in Breast Cancer and Confers Epithelial-Mesenchymal Transition. Cancer Res. 2006 Oct 1;66(19):9527-34.

Zeitz M. Erkrankungen des Magen-Darm-Traktes. Thiemes Innere Medizin 1999, 635-639.

Zheng JY, Yu D, Foroohar M, Ko E, Chan J, Kim N, Chiu R, Pang S. Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol.

2003 Aug 1;194(3):187-97.

Zheng J, Xie Y, Campbell R, Song J, Massachi S, Razi M, Chiu R, Berenson J, Yang OO, Chen IS, Pang S. Involvement of claudin-7 in HIV infection of CD4(-) cells. Retrovirology. 2005 Dec 20;2:79.